<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Proliferating cell nuclear antigen is a component of the DNA synthesome and functions in DNA replication and repair </plain></SENT>
<SENT sid="1" pm="."><plain>Our group has recently identified an acidic isoform of proliferating cell nuclear antigen, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen, that appears to be present only in malignant tissue </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to determine the presence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen in <z:mp ids='MP_0000467'>esophageal dysplasias</z:mp> and invasive <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> to assess its potential utility in discriminating <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: With a polyclonal antibody to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen, immunohistochemical staining was performed on samples from a total of 30 patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> with varying degrees of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 18 patients with invasive <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We also performed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen immunohistochemical staining on a commercially available tissue microarray and on specimens obtained from endoscopic biopsies </plain></SENT>
<SENT sid="5" pm="."><plain>As controls, immunohistochemical staining for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen was performed on <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal tissue and immunohistochemical staining for proliferating cell nuclear antigen was performed on <z:hpo ids='HP_0000001'>all</z:hpo> specimens with a commercially available antibody </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Of the <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> specimen, 14 showed no <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 8 showed low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 8 showed high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>None of these specimens stained positively for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen </plain></SENT>
<SENT sid="8" pm="."><plain>Of the 18 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> specimens, <z:hpo ids='HP_0000001'>all</z:hpo> stained positively for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen </plain></SENT>
<SENT sid="9" pm="."><plain>There was no significant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific proliferating cell nuclear antigen expression in <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal tissue, and proliferating cell nuclear antigen expression was noted to a high degree in <z:hpo ids='HP_0000001'>all</z:hpo> tissues </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>-specific proliferating cell nuclear antigen appears to demonstrate high specificity for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>This marker therefore may prove useful in differentiating <z:e sem="disease" ids="C0677898" disease_type="Neoplastic Process" abbrv="">invasive cancer</z:e> from high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>-specific proliferating cell nuclear antigen also holds future promise as a biomarker for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>